Beremagene geperpavec
id:
beremagene-geperpavec-242-12579987
title:
Beremagene geperpavec
text:
Beremagene geperpavec, sold under the brand name Vyjuvek, is a gene therapy for the treatment of wounds. Beremagene geperpavec is the first approved gene therapy to use herpes-simplex virus type 1 as a vector. Beremagene geperpavec is a genetically modified herpes-simplex virus used to deliver normal copies of the COL7A1 gene to the wounds. The most common adverse reactions include itching, chills, redness, rash, cough and runny nose. Beremagene geperpavec was approved for medical use in the Uni
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Beremagene_geperpavec
date created:
date modified:
2024-04-18T19:26:16Z
main entity:
{"identifier":"Q119475442","url":"https://www.wikidata.org/entity/Q119475442"}
image:
fields total:
13
integrity:
14